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Themolecular linkagebetweenneocortical projection
neuron subtype and area development, which en-
ables the establishment of functional areas by projec-
tion neuron populations appropriate for specific sen-
sory andmotor functions, is poorly understood. Here,
we report that Ctip1 controls precision of neocortical
development by regulating subtype identity in deep-
layer projection neurons. Ctip1 is expressed by post-
mitotic callosal and corticothalamic projection neu-
rons but is excluded over embryonic development
from corticospinal motor neurons, which instead ex-
press its close relative, Ctip2. Loss of Ctip1 function
results in a strikingbias in favorof subcerebral projec-
tion neuron development in sensory cortex at the
expense of corticothalamic and deep-layer callosal
development, while misexpression of Ctip1 in vivo
represses subcerebral gene expression and projec-
tions. As we report in a paired paper, Ctip1 also
controls acquisition of sensory area identity. There-
fore, Ctip1 couples subtype and area specification,
enabling specific functional areas to organize precise
ratios of appropriate output projections.
INTRODUCTION
The remarkable complexity of the neocortex is precisely orches-
trated during development, as many millions of neurons are born
from progenitors, migrate to birthdate-appropriate layers, adopt
subtype-specific gene expression and circuit connectivity, and
organize into modality-specific functional areas. Subtype iden-
tity is tightly correlated with birthdate; corticothalamic projection
neurons (CThPN) are born around embryonic day (E) 12.5 in
mice, are subcerebral projection neurons (SCPN) include corti-
cospinal motor neurons (CSMN) born around E13.5 and most
callosal projection neurons (CPN) born between E14.5 and
E15.5, with a minority generated and resident with deep-layerThis is an open access article under the CC BY-Nsubtypes (Woodworth et al., 2012). Nonetheless, functional
areas of the cortex vary considerably in their subtype composi-
tion; for example, many more SCPN reside in mature motor
cortex than in sensory cortex (Greig et al., 2013). This striking
reciprocal linkage between subtype and area identity, with func-
tional areas defined largely by distinctive differences in subtype
composition and therefore connectivity, has long been appreci-
ated (Brodmann, 1909; Cajal, 1899), but its molecular control
remains elusive.
Onekey transcription factor control over subtypedevelopment,
Ctip2, is expressed at high levels bySCPNand functions centrally
in SCPN terminal differentiation and connectivity (Arlotta et al.,
2005). Multiple transcription factors controlling projection neuron
specificationandpostmitotic differentiationoperate at least partly
by regulating Ctip2 expression. For example, Fezf2 regulates
SCPN differentiation by promoting expression of Ctip2 (Arlotta
et al., 2005; Chen et al., 2008; Molyneaux et al., 2005) and by pre-
venting expression of transcription factors key for specification
of alternate subtype fates, including Tbr1 (Bedogni et al., 2010;
McKenna et al., 2011) and Satb2 (Alcamo et al., 2008; Britanova
et al., 2008). Conversely, repression of Fezf2 and Ctip2 by Sox5
(Kwan et al., 2008; Lai et al., 2008; Shim et al., 2012) and Tbr1
(Bedogni et al., 2010; Han et al., 2011; McKenna et al., 2011) in
CThPN and by Satb2 (Alcamo et al., 2008; Britanova et al.,
2008) in CPN is critical for appropriate development of these sub-
types. Although these central controls begin to be expressed
immediately after neuronsexit thecell cycle, subtype identity con-
tinues to be refined as neurons mature (Azim et al., 2009), for
example, with initially promiscuous expression of Ctip2 and
Satb2 in newly postmitotic layer V neurons resolving to subtype-
specific expression in SCPN and CPN by late embryogenesis
(Alcamo et al., 2008; Britanova et al., 2008).
A paralogous zinc finger transcription factor, Ctip1 (also
known as Bcl11a/Evi9), is also expressed during development.
Ctip2 and Ctip1 are closely related, with approximately 60%
identity between their nucleotide sequences (Avram et al.,
2000; Satterwhite et al., 2001). In the hematopoietic system,
Ctip1 controls the development of B cells (Lee et al., 2013; Liu
et al., 2006, 2003) and regulates switching between fetal and
adult forms of hemoglobin (Bauer et al., 2013; Canver et al.,Cell Reports 15, 999–1012, May 3, 2016 ª2016 The Authors 999
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2015; Sankaran et al., 2008, 2009; Xu et al., 2011). Ctip1 is
expressed during development of many areas of the nervous
system, including neocortex, hippocampus, striatum, and cere-
bellum (Arlotta et al., 2008; John et al., 2012; Kuo and Hsueh,
2007; Leid et al., 2004). Although Ctip1 is known to regulate
neuronal migration (Wiegreffe et al., 2015), its functions in
neocortical subtype development are not known.
Here, we report that Ctip1 controls projection neuron subtype
identity and development of proper proportions of subtypes
within agiven functional area.Ctip1 is expressedbyCPN,CThPN,
and subplate neurons but is progressively excluded from Ctip2-
expressing CSMN. In the absence of Ctip1, SCPN expand as a
population at the expense of CThPN and deep-layer CPN, with
higher expression of genes characteristic of SCPN,more neurons
projecting to the cerebral peduncle, and a reduction in CThPN
and CPN gene expression and projections. In contrast, Ctip1
overexpression in vivo represses Ctip2 expression and reduces
the number of neurons projecting subcerebrally, while increasing
the number of neurons projecting through the corpus callosum. In
accompanyingwork, we report thatCtip1 controls the acquisition
of sensory area identity and area-specific input/output connectiv-
ity (Greig et al., 2016) and thus integrates the dual processes of
subtype and area development in neocortex.
RESULTS
CTIP1 Is Expressed by CPN, CThPN, and Subplate
Neurons but Is Largely Excluded from CSMN
CTIP1 is first detected by immunocytochemistry around E12.5 in
young postmitotic glutamatergic projection neurons in the
cortical plate (Figure 1A; Figure S1A). Immunostaining is absent
from progenitor zones at midgestation (Figures S1D–S1E00 0),
although some expression of Ctip1 mRNA can be observed by
in situ hybridization at the same age (Figures S1B and S1C), sug-
gesting that Ctip1 begins to be transcribed as neurons exit
the cell cycle, but detectable amounts of protein are not present
until postmitotic neurons migrate to the cortical plate. CTIP1
continues to be expressed by postmitotic cortical neurons
throughout embryogenesis (Figure 1B), though expression be-
gins to decrease after the first postnatal week. At postnatal
day (P) 4, CTIP1 is highly expressed throughout all six layers of
somatosensory cortex (Figures 1C and 1C0), while expression
in motor cortex is largely restricted to the subplate, layer V,
and the most superficial aspect of layer II/III.
To investigate the subtype specificity of Ctip1 expression, we
retrogradely labeled CThPN, CPN, or CSMN with Alexa fluoro-
phore-conjugated cholera toxin B (CTB) at early postnatal ages
(P1–P3) and collected labeled brains at P4. In addition, we per-
formed immunocytochemistry for CTIP1, together with FOG2,
SATB2, andCTIP2,markers of CThPN, CPN, and SCPN, respec-
tively (Woodworth et al., 2012). We find that CTIP1 is expressed
by CPN and CThPN in sensorimotor cortex but is essentially
excluded from CSMN (Figures 1D–1I). CTIP1 is expressed by
90% (±0.9%) of retrogradely labeled CThPN in layer VI and co-
localizes with FOG2 in 62% (±2.7%) of CThPN (Figures 1D and
1G). Similarly, 68% (±9.1%) of retrogradely labeled CPN express
CTIP1, andCTIP1 and SATB2 are co-expressed by 59% (±7.9%)
of CPN (Figures 1E and 1H), with no differences between super-1000 Cell Reports 15, 999–1012, May 3, 2016ficial-layer and deep-layer CPN (61% ± 7.3% superficial layer,
57% ± 9.0% deep layer, not significantly different). Few neurons
labeled retrogradely from the spinal cord express CTIP1 (4.9% ±
1.1%), and there is little co-expression of CTIP1 and CTIP2
(4.6% ± 1.4%) in motor cortex (Figures 1F and 1I).
Having determined that CTIP1 is expressed at high levels by
CThPN and CPN, but not by CSMN, we next investigated the
temporal course of CTIP1 and CTIP2 expression in embryonic
cortex. We find that at E14.5, nearly all early postmitotic layer
V neurons co-express CTIP1 and CTIP2 at high levels but that
by E17.5, CTIP1 and CTIP2 are expressed by two largely distinct
populations within layer V (Figures S3A–S3D). Given the preced-
ing retrograde labeling data (Figures 1E–1I), we reasoned that
these populations are likely immature CTIP1-expressing CPN
and CTIP2-expressing CSMN.
The early segregation of cortical CTIP1 and CTIP2 expression,
together with their functions controlling differentiation of closely
related immune cell types (Liu et al., 2003; Tydell et al., 2007;
Wakabayashi et al., 2003), led us to hypothesize that Ctip1
and Ctip2 might interact cross-repressively to control differenti-
ation of deep-layer projection neurons into distinct subtypes.
We examined Ctip2 expression in the neocortex of Ctip1/
mice and find increased levels of CTIP2 in layers V and VI by
qPCR (1.5-fold, p < 0.05). Conversely, we find increased CTIP1
expression in layers V and VI of Ctip2/ neocortex (1.5-fold,
p < 0.05; Figures S3E–S3J). These data indicate that Ctip1 and
Ctip2 are genetically cross-repressive and suggest that these
transcription factors might function to sharpen differentiation of
distinct neuronal subtypes.
More Projection Neurons Acquire SCPN Identity in the
Absence of Ctip1 Function
Because Ctip1/ mice die almost immediately after birth (Liu
etal., 2003),weobtainedCtip1fl/flmice,whichsurvive toadulthood
(Lee et al., 2013; Sankaran et al., 2008), to studyCtip1 function as
neocortical projections are established and refined. We deleted
Ctip1 specifically from cortical neurons using Emx1-Cre, which
is expressedbeginning in cortical progenitors (Gorski et al., 2002).
Because Ctip1 is expressed by CThPN and CPN but not by
CSMN, we investigated whether, in the absence of Ctip1 func-
tion, more neocortical neurons differentiate into CSMN, as well
as into SCPN more broadly. We compared wild-type and
Ctip1fl/fl;Emx1-Cre tissue at P4 by Nissl and DAPI stain and
find that conditional nulls exhibit defective cortical layering,
with a lack of clearly distinct boundaries between adjacent
layers, but that layer V, which contains SCPN, is expanded rela-
tive to other cortical layers (p < 0.01; Figures 2A–2D; Figure S2).
To investigate further, we performed immunocytochemistry and
in situ hybridization at P0 for several genes expressed by SCPN,
including CTIP2, Fezf2, andClim1 (Arlotta et al., 2005; Azim et al.,
2009; Molyneaux et al., 2005). We find that high-level expression
of these genes is expanded radially in Ctip1fl/fl;Emx1-Cre cortex,
indicating increased layer V thickness (Figures 3A–3F). This
expansion is especially striking in somatosensory cortex, where
layer V is normally thinner than in motor cortex and there are
normally fewer SCPN. In agreement with our Nissl results, this
expansion appears to be primarily in the direction of deeper
layers, suggesting that layer VIa CThPN are converted to SCPN.
Figure 1. Ctip1 Is Expressed by Postmitotic CThPN and CPN but Is Excluded from CSMN
(A–C0 ) CTIP1 immunocytochemistry on coronal brain sections. CTIP1 is expressed by newly postmitotic projection neurons in the cortical plate beginning around
E12.5 (A, arrow) and continuing through E16.5 (B) and P4 (C). At P4, CTIP1 is expressed by neurons in all layers of primary sensory cortex (C0).
(D–I) At P4, CTIP1 is expressed by CThPN and CPN but not by CSMN. CTIP1 co-localizes with FOG2, as well as with the CTB retrograde label after injection into
thalamus (D). CPN express both CTIP1 and SATB2 and are retrogradely labeled by injection of CTB into the corpus callosum (E). CSMN are retrogradely labeled
by CTB injection into the cervical spinal cord and express CTIP2 but not CTIP1 (F). Quantification, n = 4 (G–I).
CC, corpus callosum; SC, spinal cord; SP, subplate; Th, thalamus. Scale bars, 200 mm (A–C) and 40 mm (D–F). Data are represented as mean ± SEM.Expression of genes specific to CThPN, including TBR1,
FOG2, and DARPP-32 (Molyneaux et al., 2007), is markedly
reduced in P0 Ctip1fl/fl;Emx1-Cre cortex, and layer VI is radially
thinner (Figures 3G–3L). Even within the reduced domain of layer
VI, neurons expressing CThPN molecular markers and develop-
mental controls also express inappropriately high levels of
CTIP2 and Fezf2 (asterisk in Figures 3B and 3D), suggesting a
mixed SCPN/CThPN identity. TBR1 is expressed by 31% fewer
neurons in Ctip1fl/fl;Emx1-Cre cortex (p < 0.05; Figure 3T), while
32% more neurons express CTIP2 than in wild-type cortex
(p < 0.01; Figure 3S). These data strongly suggest that in the
absence of Ctip1 function, many neurons that would normally
have differentiated into CThPN have instead become SCPN.
Expression of CPN genes SATB2, LHX2, and CUX1 (Molyneaux
et al., 2009) is approximately normal in deep layers and superfi-
cial layers (Figures 3M–3R and 3U). Similarly, in conditional mu-
tants in which Ctip1 is deleted postmitotically (Ctip1fl/fl;Nex1-Cre; Goebbels et al., 2006), TBR1 expression is reduced relative
to wild-type neurons, CTIP2 expression is increased, and SATB2
expression is unchanged in both deep and superficial layers (Fig-
ures S3K–S3N), indicating that Ctip1 functions postmitotically
to specify neuronal subtype. These results demonstrate that in
the absence of Ctip1 function, more projection neurons postmi-
totically adopt an SCPN molecular identity and fewer adopt a
CThPN identity.
MoreNeuronsProject toSubcerebralTargets inCtip1fl/fl;
Emx1-CreMice, and Fewer Project to the Thalamus
We next investigated whether, beyond dysregulation of charac-
teristic subtype-specific genes, cortical projection targeting is
altered in the absence of Ctip1. We retrogradely labeled SCPN
from the cerebral peduncle at P1 (labeling all neurons projecting
to targets caudal to cerebrum), revealing that significantly more
axons project to subcerebral targets in Ctip1fl/fl;Emx1-Cre thanCell Reports 15, 999–1012, May 3, 2016 1001
Figure 2. In the Absence of Neocortical Ctip1, Cortical Layer V Is Expanded at the Expense of Cortical Layer VI
(A–H) Nissl staining and DAPI staining of cortex in wild-type mice (A and C) and Ctip1fl/fl;Emx1-Cre cortical conditional null mice (B and D) at P4. Layer V is
expanded in conditional null cortex (F and H) compared with in wild-type cortex (E and G). The asterisk in (B) and (D) marks the location of a Probst bundle.
(I) Quantification of layer thickness performed on Nissl-stained tissue, with each layer presented as a percentage of total cortical thickness (n = 5).
SP, subplate; WT, wild-type. Scale bars, 100 mm. Data are represented as mean ± SEM.in wild-type brains (Figures 4A–4C). In particular, the number of
SCPN in somatosensory cortex increases 1.4-fold (p < 0.01),
and the number of SCPN in visual cortex increases 1.2-fold
(p < 0.05). The number of SCPN in motor cortex, where CTIP1
expression is normally low (Figure 1C), does not change.
In concordance with expression of SCPN-specific genes ex-
panding deeper into layer VI (Figures 3A–3F), most additional1002 Cell Reports 15, 999–1012, May 3, 2016SCPN in Ctip1fl/fl;Emx1-Cre brains are located in the upper
portion of layer VI. By combining bromodeoxyuridine (BrdU)
birthdating at E12.5 with retrograde labeling from the cerebral
peduncle, we find that 23% of Ctip1 conditional null SCPN
have incorporated BrdU at E12.5, when CThPN are usually
generated, compared with 9% of wild-type SCPN (p < 0.01; Fig-
ures 4D–4F). In the absence ofCtip1 function, newly born layer VI
Figure 3. More Neurons in the Ctip1fl/fl;Emx1-Cre Cortex Adopt a SCPN Identity, and Fewer Adopt a CThPN Identity
(A–F) In the absence of Ctip1 function, expression of SCPN marker and control genes CTIP2, Fezf2, and Clim1 increases at P0, especially in somatosensory
cortex (A–F, arrows). Dashed lines denote superficial and deep limits of gene expression.
(G–L) In tandem, expression of the CThPN marker and control genes TBR1, FOG2, and DARPP-32 is reduced at P0. Dashed lines denote superficial and deep
limits of gene expression. Even layer VI neurons that continue to express CThPN identity genes (H, J, and L) express aberrantly high levels of CTIP2 and Fezf2
(B and D, asterisk), suggesting mixed CThPN/SCPN identity.
(M–R) CPNmarker and control genes SATB2, LHX2, and CUX1 are expressed normally at P0, although boundaries between superficial and deep layers are more
difficult to discern. Dashed lines denote superficial and deep limits of gene expression.
(S–U) Quantification of the number of neurons expressing CTIP2 (S), TBR1 (T), and SATB2 (U) in conditional null cortex, presented as a percentage of wild-type
neurons (n = 3 for each marker).
NS, not significant; WT, wild-type. *p < 0.05; **p < 0.01. Scale bars, 100 mm. Data are represented as mean ± SEM.corticofugal neurons, normally destined to differentiate into
CThPN, aberrantly differentiate into SCPN.
Because expression of genes characteristic of CThPN is
reduced in Ctip1fl/fl;Emx1-Cre cortex, and because additional
neurons projecting through the cerebral peduncle in Ctip1fl/fl;
Emx1-Cre cortex are aberrantly differentiated E12.5-born neu-
rons, we investigated CThPN projections in the absence of
Ctip1 function. We find that fewer CThPN in Ctip1fl/fl;Emx1-Cre
somatosensory cortex are retrogradely labeled by injection of
CTB into thalamus than in wild-type cortex (0.5-fold, p < 0.05;
Figures 4G–4I). Furthermore, we analyzed P0 Ctip1/mice car-
rying a Rosa26R-tdTomato reporter allele (Madisen et al., 2010)
and either anRbp4-Cre or anNtsr1-Cre allele (Gong et al., 2007),
which are specific to SCPN or CThPN, respectively. Fewer
CThPN in Ctip1/ cortex are labeled by Ntsr1-Cre than in
wild-type cortex (0.5-fold, p < 0.01), and more SCPN are labeled
by Rbp4-Cre (1.6-fold, p < 0.01; Figures 4J–4O), indicating that
fewer neurons differentiate into mature CThPN in the absence
of Ctip1. Taken together, these results indicate that Ctip1 con-
trols the development of CThPN by suppressing their alternative
differentiation into SCPN.
CPN Pathfinding Is Disrupted in the Absence of Ctip1
Function
Ctip1fl/fl;Emx1-Cre mice exhibit partial agenesis of the corpus
callosum, with prominent Probst bundles containing axons that
have failed to cross themidline (asterisk in Figures 2B and 2D; Ri-chards et al., 2004), and the corpus callosum is thinner inCtip1fl/fl;
Emx1-Cre than in wild-type mice (Figures 2A–2D). These data
indicate that development of the callosal projection is disrupted
in the absence of Ctip1. In addition, many superficial-layer neu-
rons in cingulate cortex, normally the earliest-crossing callosal
population (Koester and O’Leary, 1994), are instead retrogradely
labeled by injection of CTB from the cerebral peduncle (Figures
5A and 5B), suggesting that pioneering cingulate cortex CPN in
Ctip1fl/fl;Emx1-Cre brains are fate converted to SCPN. Consis-
tent with this interpretation, superficial-layer neurons in cingulate
cortex fail to express genes typical of cingulate cortex CPN, such
as Dkk3 and Lpl (Figures 5C–5F; Molyneaux et al., 2009), and
instead aberrantly express CTIP2 (Figures 5G and 5H).
Potentially because cingulate CPN fail to pioneer the callosum,
fewer deep-layer neurons in somatosensory cortex cross the
callosum in Ctip1fl/fl;Emx1-Cre cortex than in wild-type mice
(p < 0.01; Figures 5I–5K). Strikingly, layer VI CPN are more
severely affected (56% fewer cross, p < 0.01) than layer V CPN
(19% fewer cross, p < 0.05), suggesting that many later-born
CPN are able to follow the few early-born CPN that manage to
cross the midline, even in the absence of a fully functional cingu-
late pioneer population. However, even projections of later-born
CPN are cell-autonomously disrupted in the absence of Ctip1,
because Cre electroporation into Ctip1fl/fl cortex at E15.5 results
in 52% fewer axons crossing the callosum (p < 0.01; Figures S5I–
S5K). These data indicate that axon pathfinding is disrupted in
CPN across all layers of cortex in the absence of Ctip1.Cell Reports 15, 999–1012, May 3, 2016 1003
Figure 4. More Neurons in theCtip1fl/fl;Emx1-Cre Somatosensory and Visual Cortex Project toward Subcerebral Targets, and Fewer Project
toward Thalamic Targets
(A–B0) More neurons inCtip1 conditional null somatosensory cortex (B and B0) are retrogradely labeled by injection of CTB into the cerebral peduncle than in wild-
type cortex (A and A0).
(C) Quantification of retrogradely labeled SCPN by area, presented as a percentage of wild-type SCPN in each area (n = 3).
(D–F) Additional SCPN inCtip1fl/fl;Emx1-Cre brains are aberrantly differentiated from E12.5-born neurons. More neurons labeled by injection of BrdU at E12.5 are
co-labeled by injection of CTB into the cerebral peduncle in conditional null cortex (E) compared with in wild-type cortex (D). Arrowheadsmark representative co-
labeled neurons. Quantification, n = 4 (F).
(G–I) Compared with wild-type cortex (G), fewer CThPN are retrogradely labeled in somatosensory cortex of Ctip1fl/fl;Emx1-Cre mutants (H) following CTB
injection into sensory thalamic nuclei. Quantification, n = 3 (I).
(J–O)Ctip1 null cortex contains moremature SCPN and fewer mature CThPN than does wild-type cortex. More neurons are marked by SCPN-specificRbp4-Cre
in Ctip1/ P0 cortex (K) compared with in wild-type cortex (J; n = 4). In contrast, fewer neurons are marked by CThPN-specific Ntsr1-Cre in null P0 cortex (N)
compared with in wild-type cortex (M; n = 3). Quantification (L and O). Recombination by Rbp4-Cre and Ntsr1-Cre is reported by a Rosa26R-tdTomatofl allele.
NS, not significant; WT, wild-type. *p < 0.05; **p < 0.01. Scale bars, 100 mm (A, B, G, H, J, K, M, and N) and 50 mm (D and E). Data are represented asmean ± SEM.Although the corpus callosum is thinner in Ctip1fl/fl;Emx1-Cre
mice, the anterior commissure (AC) is notably enlarged (arrows
in Figures 5L and 5M). Many neurons in Ctip1fl/fl;Emx1-Cre
somatosensory cortex are retrogradely labeled by injection of1004 Cell Reports 15, 999–1012, May 3, 2016CTB into the AC, while retrogradely labeled neurons are not
present in this location in wild-type somatosensory cortex (Fig-
ures 5N–5R). These data indicate that in the absence of Ctip1
function, many commissural neurons aberrantly project to the
Figure 5. Cingulate CPN Fail to Pioneer the Callosum in the Absence of Ctip1 Function, Impairing Projections of Deep-Layer CPN
(A–H) Superficial-layer neurons in Ctip1fl/fl;Emx1-Cre cingulate cortex aberrantly project through the cerebral peduncle (A and B), fail to express cingulate CPN
genes Dkk3 (C and D) and Lpl (E and F), and instead express CTIP2 (G and H).
(I–K) Failure of cingulate CPN to pioneer the corpus callosum results in a reduction of retrogradely labeled deep-layer CPN in Ctip1fl/fl;Emx1-Cre cortex. Fewer
CPN are retrogradely labeled in P4 Ctip1fl/fl;Emx1-Cre layers V and VI (J and J0) compared with in wild-type cortex (I and I0). Quantification of (I) and (J) as a
percentage of wild-type deep-layer CPN, n = 3 (K). Layer VI CPN are more severely affected than layer V CPN. Schematic of injection site, upper right corner.
(L–R) More neurons in Ctip1 conditional null brains aberrantly project to the contralateral hemisphere via the AC pathway. The AC is abnormally enlarged in P4
Ctip1fl/fl;Rosa26R-tdTomatofl/wt;Emx1-Cre brains (M, arrow) comparedwithCtip1wt/wt;Rosa26R-tdTomatofl/wt;Emx1-Cre (wild-type) brains (L, arrow). Retrograde
labeling from the contralateral hemisphere at P1 reveals that additional AC-projecting neurons in Ctip1 conditional null brains are aberrantly located in
somatosensory cortex, an area where AC-projecting neurons are not normally located (N, O, Q, and R). Schematic of injection site (P).
*p < 0.05; **p < 0.01. Scale bars, 100 mm (A–J), 50 mm (I0 and J0), 500 mm (L and M), and 200 mm (N–R). Data are represented as mean ± SEM.contralateral hemisphere via this abnormal AC route instead of
via the corpus callosum.
Late-Born Projection Neurons Migrate Abnormally in
Ctip1 Mutants
Although superficial-layer CPN outside cingulate cortex are not
fate converted to SCPN in Ctip1fl/fl;Emx1-Cre mice (Figures
4A–4B0), superficial-layer neurons are improperly laminated (Fig-ures 2A–2D, 5I, and 5J) and impaired in their projections (Figures
S5I–S5K). To investigate whether Ctip1fl/fl;Emx1-Cre neurons
form imprecise layers as a result of abnormal migration, we birth-
dated cortical neurons in conditional null and wild-type cortex by
injecting BrdU into pregnant females at E11.5, E12.5, E13.5,
E14.5, and E15.5. We analyzed the laminar position of labeled
neurons at P4, after migration is normally complete. We find
significant numbers of E14.5-born and E15.5-born neuronsCell Reports 15, 999–1012, May 3, 2016 1005
Figure 6. In the Absence of Neocortical Ctip1, Superficial-Layer Projection Neurons Migrate Aberrantly and Become Inappropriately
Positioned in Cortex
(A–F) Wild-type neurons labeled by BrdU injection at E14.5 (A and A0) or E15.5 (D and D0) are primarily located in superficial layers, while Ctip1fl/fl;Emx1-Cre
neurons labeled by BrdU at E14.5 (B and B0) or E15.5 (E and E0) are frequently ectopically located in deep layers. The overall laminar distribution of labeled neurons
(marked in red in A0, B0, D0, and E0 ) is strikingly abnormal (C and F). Bin 1 is the most superficial bin, and bin 10 is the deepest.
(G) Quantification of (A)–(F), with bins 1–4 grouped as the ‘‘upper’’ cortical segment, bins 5–7 as ‘‘middle,’’ and bins 8–10 as ‘‘deep.’’
(H–K) Sparse electroporation of Cre at E14.5 causes Ctip1fl/fl neurons to be delayed in the intermediate zone rather than migrate into the cortical plate at E17.5.
Schematic of experimental approach (H). Wild-type neurons electroporated with Cre (I) are significantly more likely than electroporated Ctip1fl/fl neurons (J) to
have migrated into the cortical plate by E17.5 (quantification, K).
CP, cortical plate; IZ, intermediate zone; VZ, ventricular zone. *p < 0.05; **p < 0.01. Scale bars, 200 mm (A, B, D, and E) and 50 mm (A0, B0, C0, D0, I, and J). Data are
represented as mean ± SEM.ectopically located in deep layers in Ctip1fl/fl;Emx1-Cre mutants
(p < 0.05 for neurons located in bins 5, 6, and 7 at both E14.5 and
E15.5; Figures 6A–6G), indicating that late-born projection neu-
rons fail to migrate appropriately to superficial layers. These
neurons express markers of superficial-layer neurons, such as
CUX1, appropriate to their birthdate but not their laminar position
(Figures S5F–S5H). In contrast, migration of neurons born at1006 Cell Reports 15, 999–1012, May 3, 2016E11.5, E12.5, or E13.5 is not significantly affected (Figures
S6A–S6I). These results indicate that many late-born Ctip1fl/fl;
Emx1-Cre neurons migrate and become positioned in deep-
layer cortex, leading to abnormal lamination of the cortex as a
whole.
Migration defects in Ctip1fl/fl;Emx1-Cre animals might be due
to defective signaling to migrating neurons from postmigratory
neurons in the cortical plate, or they might be due to aberrant
interpretation of cues by migrating neurons. To distinguish be-
tween these possibilities, we electroporated E14.5 wild-type
or Ctip1fl/fl embryos with cytomegalovirus (CMV)/b-actin pro-
moter-driven Cre and lox-STOP-lox-Egfp constructs and exam-
ined electroporated tissue at E17.5 (Figure 6H). This experiment
deletes Ctip1 from only a fraction of cortical neurons, allowing
sparse deletion of Ctip1 in an otherwise wild-type context.
Ctip1fl/fl neurons electroporated with Cre at E14.5 are four times
less likely than wild-type electroporated neurons to have entered
the cortical plate at E17.5 (13% Ctip1fl/fl versus 51% wild-type,
p < 0.01; Figures 6I–6K), indicating that migration abnormalities
of superficial-layer neurons lacking Ctip1 are cell autonomous.
Furthermore, these defects are specific to neurons migrating
to the superficial layers, because migration of Ctip1fl/fl neurons
electroporated with Cre at E12.5 and examined at E15.5 is unaf-
fected (not significant; Figures S6J–S6M).
Ctip1 Overexpression Represses CTIP2 in Layer V
Neurons, Preventing Them from Extending Axons
Subcerebrally
To further investigate potential functions ofCtip1 in repression of
CSMN and SCPN specification, we tested whether overexpres-
sion ofCtip1 in vivo can repress endogenous expression ofCtip2
by wild-type CSMN. We electroporated CMV/b-actin promoter
constructs driving expression of either control IRES-nEgfp
(nuclear EGFP) or Ctip1-IRES-nEgfp into the ventricular zone
of E12.5 wild-type embryos and examined CTIP2 expression
at P4 by immunocytochemistry (Figures 7B–7C00). Strikingly,
while many control E12.5 Egfp-electroporated layer V neurons
are CTIP2 positive (39%), as expected, significantly fewer
Ctip1-electroporated layer V neurons are CTIP2 positive (7%,
p < 0.01). These data demonstrate that high levels of CTIP1
are sufficient to repress expression of Ctip2.
Conversely, overexpression of Ctip2 or Fezf2 can repress
endogenous Ctip1 in layer V neurons. When we electroporate
Ctip2-IRES-nEgfp or Fezf2-IRES-nEgfp at E12.5, we find that
fewer layer V neurons express Ctip1 at P4 compared with
layer V neurons electroporated with control IRES-nEgfp (nEgfp,
64%; Fezf2, 37%, p < 0.01; Ctip2, 8%, p < 0.01; Figure S7).
High-level expression either of Ctip2 or Fezf2 is therefore suffi-
cient to repress expression of Ctip1, although Ctip2 is more effi-
cient than Fezf2.
This cross-repression between Ctip1 and Ctip2/Fezf2, central
transcriptional controls over SCPN development, motivated us
to investigate whether Ctip1 is also sufficient to prevent layer V
neurons from projecting subcerebrally. We electroporated con-
trol IRES-nEgfp or Ctip1-IRES-nEgfp constructs into wild-type
embryos at E12.5 and then retrogradely labeled CSMN or CPN
with CTB (Figure 7A). Strikingly, we find a 5-fold reduction in
the percentage of Ctip1-electroporated neurons projecting to
the spinal cord, compared with control nEgfp-electroporated
neurons (25% versus 6%, p < 0.01; Figures 7F–7H). Further-
more, we find a significant increase in the number of Ctip1-elec-
troporated layer V neurons projecting across the corpus cal-
losum (13% nEgfp versus 20% Ctip1, p < 0.05; Figures 7I–7K),
indicating that the axons of some Ctip1-electroporated neurons
are redirected from subcerebral targets and toward contralateralcortical targets. Taken together, these data demonstrate that
Ctip1 overexpression alters the balance of deep-layer projection
neuron fate specification against SCPN and in favor of CPN in
both gene expression and axonal projections.
DISCUSSION
Although critical molecular controls over projection neuron sub-
type development have been identified in recent years, it is clear
that additional transcriptional regulators remain to be discov-
ered, particularly those that exert fine control over the final distri-
bution, proportions, and balance of subtypes present in specific
functionally specialized areas of the cortex. In this work, we iden-
tify that the transcription factor Ctip1 directs the proportional
allocation of CThPN, SCPN, and CPN in deep cortical layers.
Subtype Control over Deep-Layer Neurons
Ctip1 controls the balance between specification of distinct,
functionally specialized subtypes of deep-layer cortical projec-
tion neurons, and in the absence of Ctip1 function, more SCPN
are generated at the expense of CThPN and deep-layer CPN.
In Ctip1fl/fl;Emx1-Cre mice, an aberrantly expanded population
of neurons with molecular and anatomic characteristics of
SCPN occupies an expanded layer V (Figure 3), and more neu-
rons born at E12.5 send axons to the cerebral peduncle instead
of to the thalamus, indicating that CThPN located in the upper
segment of what would otherwise be layer VI are fate converted
to SCPN (Figure 4).
The population of CThPN located in the most superficial
portion of layer VI, near the interface between layer V and layer
VI, is particularly vulnerable to switching fate from corticothala-
mic to subcerebral due to ectopic expression of SCPN genetic
controls (Lai et al., 2008; Tomassy et al., 2010). In the absence
of Ctip1, all layer VI neurons express higher-than-normal levels
of Fezf2 and Ctip2 (asterisk in Figures 3B and 3D); however,
only those neurons located in themost superficial portion of layer
VI cease to express CThPN controls (Figures 3G–3L) and conse-
quently project subcerebrally (Figures 4A–4F). The existence of
this subpopulation of CThPN, which is generated immediately
before SCPN specification begins and resides immediately adja-
cent to layer V, suggests that these closely related corticofugal
neurons require precise transcriptional control by Ctip1 and
other genes for correct specification into distinct projection
neuron subtypes and for allocation of correct proportions of
CThPN and SCPN depending on cortical area.
Ctip1 controls subtype specification but is non-subtype spe-
cific, because it is expressed at high levels by CPN, CThPN,
and subplate neurons. Although some previously identified con-
trols are expressed by multiple subtypes, they are generally ex-
pressed at high levels by one subtype and low levels by another:
Ctip2 and Fezf2 by SCPN (high) and CThPN (low); Tbr1 by
CThPN (high) and superficial-layer CPN (low); and Sox5 by
CThPN (high) and SCPN (low; Arlotta et al., 2005; Hevner et al.,
2001; Lai et al., 2008; McKenna et al., 2011; Molyneaux et al.,
2005; Woodworth et al., 2012). Ctip1, in contrast, is specific
only in its exclusion fromCSMN (Figures 1D–1I). This widespread
and non-subtype-specific expression is most likely responsible
for Ctip1 not being identified as a candidate in microarray-basedCell Reports 15, 999–1012, May 3, 2016 1007
Figure 7. CTIP1 Misexpression In Vivo Represses SCPN Identity and Projection to the Spinal Cord
(A) Schematic of experimental approach. Wild-type embryos were electroporated at E12.5, and retrograde labeling from the spinal cord (F and G) or from the
contralateral cortical hemisphere (I and J) was performed on electroporated pups at P2 or P3, respectively. Brains were collected at P4, and somatosensory
cortex was imaged and analyzed.
(B–C00) Many neurons electroporated with control nEgfp at E12.5 express CTIP2 (B–B00; 39%), while few neurons electroporated with Ctip1-IRES-nEgfp express
CTIP2 (C–C00; 7%; n = 3).
(D–K) Misexpression ofCtip1 causes E12.5-born neurons to redirect their axons away from the brainstem and spinal cord and toward targets on the contralateral
cortical hemisphere. Neurons electroporated withCtip1-IRES-Egfp at E12.5 send few axons to the brainstem (whole-mount electroporated brains in D and E and
coronal brainstem sections in D0 and E0). Fewer neurons electroporated at E12.5 with Ctip1-IRES-nEgfp are retrogradely labeled by spinal cord injection at P2
than those electroporated with control nEgfp (F and G; quantification in H, n = 3), while more Ctip1-electroporated neurons than control nEgfp-electroporated
neurons are retrogradely labeled by injection into the corpus callosum (I and J; quantification in K, n = 3).
**p < 0.01. Scale bars, 50 mm (B, C, F, G, I, and J), 1 mm (D and E), and 100 mm (D0 and E0). Data are represented as mean ± SEM.screens for genes involved in subtype specification (Arlotta et al.,
2005; Chen et al., 2005a, 2005b). The data presented here
regarding Ctip1 function suggest that further unidentified con-
trols over subtype development might expand or contract popu-
lations of neurons by action in developmentally, and likely evolu-
tionarily, related populations.1008 Cell Reports 15, 999–1012, May 3, 2016Abnormalities of Commissural Neurons
In the absence of Ctip1 function, fewer deep-layer CPN project
through the corpus callosum (Figures 5I–5K); instead, many
deep-layer neurons in somatosensory cortex project to the
contralateral hemisphere via the AC (Figures 5L–5R). This re-
routing might be necessary because the superficial-layer
neurons in cingulate cortex that would normally pioneer the cal-
losal projection instead aberrantly project through the pyramidal
tract (Figures 5A–5H), impairing pathfinding by deep-layer CPN.
Alternatively, more AC-projecting neurons might be specified in
the absence ofCtip1 function, reflecting a previously unidentified
balance between specification of corpus callosum (CC)-projec-
ting and AC-projecting commissural neurons controlled, at least
partly, by Ctip1. We do not exclude the possibility that Ctip1
might regulate expression of axon guidance molecules neces-
sary for pathfinding by CPN. Ctip1 might regulate pathfinding
in SCPN and CThPN as well, particularly in light of aberrant sub-
plate neuron gene expression and axon extension in null mice
(Figure S4).
In contrast with these striking abnormalities of deep-layer CPN
targeting, Ctip1fl/fl;Emx1-Cre superficial-layer CPN neither ex-
press SCPN-specific controls (Figures 3A–3F) nor project
through the cerebral peduncle (Figures 4A–4B0), except in cingu-
late cortex (Figures 5A–5H). Ctip1 is expressed at high levels by
superficial-layer CPN (Figure 1C), but these neurons appear to
be specified largely normally in the absence of Ctip1 (Figures
3M–3R), although many of their axons do not successfully cross
the corpus callosum (Figures S5I–S5K). These data are consis-
tent with the hypothesis that superficial-layer and deep-layer
CPN are substantially different from each other molecularly
and with regard to their developmental origins, perhaps reflect-
ing distinct evolutionary events of projection neuron diversifica-
tion (Arlotta et al., 2008; Fame et al., 2011; Molyneaux et al.,
2009). Ctip1 is expressed by both superficial-layer and deep-
layer CPN but is necessary for subtype specification only for
deep-layer CPN, which appear to bear a closer relationship to
concurrently generated corticofugal projection neurons (Greig
et al., 2013; Sohur et al., 2014). Loss of Ctip1 function contrasts
starkly with the loss-of-function phenotype observed for another
important negative regulator of SCPN development, Satb2, in
which large numbers of both superficial-layer and deep-layer
neurons aberrantly express SCPN controls such as CTIP2 (Al-
camo et al., 2008; Britanova et al., 2008; Srinivasan et al.,
2012). This contrast indicates that an increasingly rich set
of molecular regulators controls both novel and subtle, but
likely functionally critical, aspects of precise projection neuron
development.
Ctip1 and Ctip2 Interact Cross-repressively in
Developing Cortex
Ctip1 and Ctip2, paralogous and highly similar transcription fac-
tors, are initially co-expressed in developing cortex (Figures
S3A–S3B) but later are expressed complementarily, with CTIP1
expressed by CPN and CThPN and CTIP2 expressed by SCPN
(Figures 1D–1F; Figures S3C–S3D). Expression of CTIP2 in-
creases in the absence of Ctip1, and expression of CTIP1 in-
creases in the absence ofCtip2 (Figures S3E–S3J). Furthermore,
overexpression of either Ctip1 or Ctip2 at E12.5 in vivo is suffi-
cient to repress expression of the other (Figures 7B–7C00; Figures
S7A and S7C). From these data, we conclude that Ctip1 and
Ctip2 cross-repressively interact to control the development of
cortical projection neurons. Ctip1 and Ctip2 exhibit similar pat-
terns of exclusive expression in development of other cell types;
Ctip1 expression is sharply downregulated asCtip2 begins to beexpressed inmaturing T cells (Tydell et al., 2007), and expression
ofCtip1 is significantly increased in P0Ctip2/ striatal medium-
sized spiny neurons (Arlotta et al., 2008).
Our model of Ctip1 function is at odds with that of Ca´novas
et al. (2015), who proposed that CTIP1 is extensively co-ex-
pressedwith CTIP2 and is a positive control over SCPN develop-
ment through repression of TBR1. In direct contrast, we demon-
strate that expression of TBR1 and other characteristic CThPN
genes is reduced in the absence of Ctip1 (Figures 3G–3L and
4M–4O) and that expression of CTIP2 is increased (Figures 3A
and 3B), leading to more early-born neurons becoming SCPN
(Figures 4A–4F). These discrepancies likely result from different
loss-of-function approaches, as our investigation uses null and
conditional null mouse lines, rather than modest knockdown of
Ctip1 using mosaic small hairpin RNA electroporation in wild-
type animals.
Ctip1 as a Candidate Human Intellectual Disability Gene
CTIP1 is highly conserved frommouse to human, with only three
amino acid substitutions (99.6% identity) between the longest
mouse and the longest human CTIP1 isoforms, and Ctip1 and
its promoter are located within one of the most ultraconserved
non-coding region-rich stretches of the human genome (Sande-
lin et al., 2004). CTIP1 is expressed in fetal human brain (Satter-
white et al., 2001), although the subtype specificity of its expres-
sion in human brain is not known. Ctip1 is one of three protein-
coding genes consistently deleted in 2p15-p16.1 microdeletion
syndrome, which is characterized by intellectual disability, by
microcephaly, and frequently by autistic behavior (Hancarova
et al., 2013). A patient with a de novo Ctip1 microdeletion has
been reported with severe speech sound disorder and intellec-
tual delay (Peter et al., 2014). These phenotypes are consistent
with functions of Ctip1 in the subtype-specific differentiation
and migration of neocortical projection neurons, suggesting
that Ctip1 also functions critically in organizing the human
neocortex.
Ctip1 Couples Development of Projection Neuron
Subtypes and Cortical Areas
Although subtype and area development are typically analyzed
as independent developmental vectors in the emergence of the
mature neocortex, the two are highly interdependent, because
the proportion and identity of neuron subtypes varies signifi-
cantly by cortical area (Brodmann, 1909; Cajal, 1899). Molecular
programs controlling subtype and area differentiation likely
interact at multiple nodes; here, we identify Ctip1 as a central
node. Ctip1 directs the proportional allocation of SCPN and
CThPN in sensory cortex, and in the absence of Ctip1, sensory
cortical areas are transformed, with subtype compositions,
gene expression, and output connectivity that are usually pre-
sent in motor areas (Figures 3 and 4; Greig et al., 2016). Strik-
ingly, the expression (Figure 1; Figure S1) and functions (Fig-
ure S3) of Ctip1 in postmitotic neurons indicate that this
regulation of subtype composition in distinct cortical areas oc-
curs postmitotically. Therefore, the final non-uniform distribution
of cortical projection neuron subtypes across cortical areas is
based, at least partly, on differences not in subtype production
but in subtype differentiation.Cell Reports 15, 999–1012, May 3, 2016 1009
In conclusion, our results indicate that Ctip1 is a central func-
tional control over the precision of neocortical development.
Ctip1 directs the development of CThPN and CPN at multiple
stages. First, Ctip1 specifies subtype identity in deep-layer
neocortical projection neurons, preventing CThPN and CPN
from acquiring characteristics of SCPN. Second, Ctip1 directs
the development of cingulate cortex neurons, allowing these
populations to pioneer callosal projections. Finally, Ctip1 en-
ables the proper migration and laminar positioning of superfi-
cial-layer CPN, permitting these neurons to populate correct
laminar locations. Identification of further fine transcriptional
controls over the precise differentiation, diversity, positioning,
and connectivity of neocortical projection neurons will increas-
ingly illuminate the staggering organizational and functional
complexity of the mature neocortex and provide insight into
overt and subtle dysgenesis that can result in human cognitive,
sensory, motor, and integrative disorders.
EXPERIMENTAL PROCEDURES
Animals
All mouse studies were approved by the Harvard University Institutional Ani-
mal Care and Use Committee and were performed in accordance with insti-
tutional and federal guidelines. The date of vaginal plug detection was desig-
nated E0.5, and the day of birth was designated P0. Unless noted otherwise,
all experiments with Ctip1fl/fl;Emx1-Cre were controlled with Ctip1wt/wt;Emx1-
Cre, and those with Ctip1/ were controlled with Ctip1wt/wt, although no
abnormal phenotypes were observed in Ctip1/wt or Ctip1fl/wt;Emx1-Cre het-
erozygotes. Sources of mouse lines used are described in Supplemental
Information.
Immunocytochemistry and In Situ Hybridization
Mice were transcardially perfused with 4% paraformaldehyde, and brains
were dissected and postfixed at 4C overnight. Tissue was sectioned
at 50 mm on a vibrating microtome (Leica). Non-specific binding was
blocked by incubating tissue and antibodies in 8% goat serum/0.3% BSA in
PBS. For DAPI staining, tissue was mounted in DAPI-Fluoromount-G
(SouthernBiotech). Antibodies and in situ probes used are described in Sup-
plemental Information.
BrdU Birthdating
Timed pregnant females were intraperitoneally injected with BrdU (50mg/kg in
PBS) at E11.5, E12.5, E13.5, E14.5, or E15.5. Tissue was collected at P4 and
processed for BrdU immunocytochemistry (Magavi and Macklis, 2008).
For analysis of BrdU-labeled SCPN, BrdU labeling was performed as earlier
at E12.5, and littermate pairs were retrogradely labeled from the cerebral
peduncle as described later.
For acute BrdU administration, timed pregnant females were intraperitone-
ally injected with BrdU (75 mg/kg) at E14.5, and embryos were collected
30 min later.
In Utero Electroporation
For overexpression experiments, a CMV/b-actin promoter plasmid (derived
from pCBIG; gift of C. Lois) was used to drive expression of IRES-Egfp (control)
or Ctip1 XL-IRES-Egfp (experimental; coding sequence from NM_001242934)
or of IRES-nEgfp (control) or Ctip1 XL-IRES-nEgfp, Ctip2-IRES-nEgfp, or
Fezf2-IRES-nEgfp (experimental) in CD1 timed pregnant females at E12.5.
For some experiments, pups were screened for Egfp expression on a fluores-
cent dissecting microscope at birth, and pups electroporated in somatosen-
sory cortex were retrogradely labeled (as described later). Brains were
collected at P4.
For loss-of-function experiments, two CMV/b-actin promoter plasmids
were co-electroporated, driving expression of lox-STOP-lox-Egfp and Cre
in Ctip1wt/wt (control) or Ctip1fl/fl (experimental) embryos. Plasmids were1010 Cell Reports 15, 999–1012, May 3, 2016electroporated at E12.5 (Figure S6), E14.5 (Figure 6), or E15.5 (Figure S5),
and brains were collected either 72 hr later (Figure 6; Figure S6) or at P4 (Fig-
ure S5). Electroporation conditions were described previously (Molyneaux
et al., 2005).
Retrograde Labeling
Projection neuronswere labeled from their axon termini under ultrasound guid-
ance by pressure injection of Alexa fluorophore-conjugated CTB (Invitrogen).
SCPN were labeled by injection into the cerebral peduncle at P1, CThPN
were labeled by injection into sensory thalamic nuclei (ventral posteromedial
and ventral posterolateral) at P1, CSMN were labeled by injection into the cer-
vical spinal cord at P2, and CPNwere labeled by injection into the contralateral
corpus callosum at P3. AC-projecting neurons were labeled by injection into
contralateral AC at P1. Tissue for all injections was collected at P4 and pro-
cessed as for immunocytochemistry.
Quantification and Statistics
Littermate pairs of experimental and control mice were collected at the age
indicated in the figure and processed as for immunocytochemistry. Anatomi-
cally matched sections from each mouse (generally at the level of the AC, un-
less otherwise noted) were selected, and single confocal slices of somatosen-
sory cortex were imaged. Cells positive for the indicated marker or markers
(retrograde label, protein by immunocytochemistry, BrdU label, orGFPby elec-
troporation) were counted within a box of pre-defined size spanning the radial
thickness of cortex, with the same size of box applied to wild-type and mutant
images. Except where specifically noted (Figure 2; Figure S2), data are not cor-
rected for differences in cortical thickness between wild-type and mutant ani-
mals (Table S1). Statistical analyseswere conducted using unpaired two-tailed
t tests in Microsoft Excel, with a significance threshold of p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.03.064.
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